• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非 Hunner 溃疡间质性膀胱炎/膀胱疼痛综合征患者的排尿功能障碍并不影响长期治疗效果。

Voiding dysfunctions in patients with non-Hunner's ulcer interstitial cystitis/bladder pain syndrome do not affect long-term treatment outcome.

机构信息

Department of Nursing, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.

Department of Medical Research, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.

出版信息

Int J Clin Pract. 2021 Sep;75(9):e14372. doi: 10.1111/ijcp.14372. Epub 2021 May 29.

DOI:10.1111/ijcp.14372
PMID:33998747
Abstract

PURPOSE

The role of urodynamic study in the diagnosis and prognostication of interstitial cystitis/bladder pain syndrome (IC/BPS) is still controversial. This study evaluated the correlation of the baseline voiding dysfunctions and long-term treatment outcome in patients with non-Hunner's ulcer IC (NHIC).

MATERIALS AND METHODS

A total of 211 NHIC patients were enrolled. All patients underwent videourodynamic (VUDS) examination at baseline to identify their voiding conditions and received subsequent treatments. The primary endpoint was Global Response Assessment (GRA) at the interview. Secondary endpoints included O'Leary-Sant symptom score (OSS), Visual Analogue Scale (VAS) for pain and the rate of IC symptom flare-up.

RESULTS

The mean age was 56.8 ± 12.8 years, and mean duration of IC was 16.0 ± 9.9 years. At baseline, 83 (39.3%) patients had a voiding dysfunction and 132 (62.7%) had 1 to 3 co-morbidities. The duration, co-morbidities, treatments, changes in OSS and VAS, maximum bladder capacity (MBC), glomerulations, GRA and flare-up rate showed no significant difference among different subgroups. When we divided patients by their storage and voiding conditions, patients with non-hypersensitivity bladder (HSB) (n = 32) had significantly greater MBC (P = .002) whereas those with HSB with (n = 76) or without (n = 103) voiding dysfunction had higher glomerulation (P = .021). When we analysed voiding dysfunction subgroups by GRA, patients with a GRA of ≥2 had a significantly shorter duration of disease (13.9 ± 8.6 years, P = .021). There were also significant associations between GRA and the changes of OSS (P < .001) and VAS (P < .001).

CONCLUSIONS

VUDS can disclose voiding dysfunction in 39.3% of NHIC patients. With adequate therapy, the voiding dysfunctions in NHIC patients do not affect long-term treatment outcome.

摘要

目的

尿动力学检查在间质性膀胱炎/膀胱疼痛综合征(IC/BPS)的诊断和预后中的作用仍存在争议。本研究评估了非 Hunner 溃疡型 IC(NHIC)患者基线排尿功能障碍与长期治疗结果的相关性。

材料和方法

共纳入 211 例 NHIC 患者。所有患者在基线时均行视频尿动力学(VUDS)检查以确定其排尿情况,并接受后续治疗。主要终点是访谈时的总体反应评估(GRA)。次要终点包括 O'Leary-Sant 症状评分(OSS)、疼痛视觉模拟评分(VAS)和 IC 症状发作率。

结果

患者平均年龄为 56.8±12.8 岁,IC 平均病程为 16.0±9.9 年。基线时,83 例(39.3%)患者存在排尿功能障碍,132 例(62.7%)存在 1 至 3 种合并症。不同亚组之间的病程、合并症、治疗方法、OSS 和 VAS 变化、最大膀胱容量(MBC)、肾小球、GRA 和发作率无显著差异。当我们根据患者的储存和排尿情况进行分组时,非高敏感膀胱(HSB)患者(n=32)的 MBC 显著更大(P=0.002),而 HSB 伴有(n=76)或不伴有(n=103)排尿功能障碍的患者肾小球发生率更高(P=0.021)。当我们根据 GRA 分析排尿功能障碍亚组时,GRA≥2 的患者疾病持续时间明显较短(13.9±8.6 年,P=0.021)。GRA 与 OSS(P<0.001)和 VAS(P<0.001)变化之间也存在显著相关性。

结论

VUDS 可发现 39.3%的 NHIC 患者存在排尿功能障碍。经过充分治疗,NHIC 患者的排尿功能障碍不会影响长期治疗效果。

相似文献

1
Voiding dysfunctions in patients with non-Hunner's ulcer interstitial cystitis/bladder pain syndrome do not affect long-term treatment outcome.非 Hunner 溃疡间质性膀胱炎/膀胱疼痛综合征患者的排尿功能障碍并不影响长期治疗效果。
Int J Clin Pract. 2021 Sep;75(9):e14372. doi: 10.1111/ijcp.14372. Epub 2021 May 29.
2
Repeated intravesical onabotulinumtoxinA injections are effective in treatment of refractory interstitial cystitis/bladder pain syndrome.经尿道重复注射肉毒毒素 A 治疗难治性间质性膀胱炎/膀胱疼痛综合征有效。
Int J Clin Pract. 2013 May;67(5):427-34. doi: 10.1111/ijcp.12113.
3
Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis.膀胱内注射肉毒毒素 A 对溃疡型间质性膀胱炎患者无益。
Pain Physician. 2013 Mar-Apr;16(2):109-16.
4
Cystoscopic hydrodistention characteristics provide clinical and long-term prognostic features of interstitial cystitis after treatment.膀胱镜下液压扩张特征为治疗后间质性膀胱炎的临床和长期预后特征提供了依据。
Sci Rep. 2021 Jan 11;11(1):455. doi: 10.1038/s41598-020-80252-x.
5
Videourodynamic characteristics of interstitial cystitis/bladder pain syndrome-The role of bladder outlet dysfunction in the pathophysiology.间质性膀胱炎/膀胱疼痛综合征的尿动力学特征——膀胱出口功能障碍在发病机制中的作用。
Neurourol Urodyn. 2018 Aug;37(6):1971-1977. doi: 10.1002/nau.23542. Epub 2018 Mar 5.
6
Pelvic Floor Myofascial Pain Might Influence Treatment Outcome of Interstitial Cystitis/Bladder Pain Syndrome: A Prospective Study.盆腔底肌筋膜疼痛可能影响间质性膀胱炎/膀胱疼痛综合征的治疗效果:一项前瞻性研究。
Pain Physician. 2022 Nov;25(8):E1315-E1322.
7
Does repeated hydrodistension with transurethral fulguration for interstitial cystitis with Hunner's lesion cause bladder contraction?经尿道电灼联合反复膀胱水扩张治疗间质性膀胱炎(Hunner溃疡型)是否会导致膀胱挛缩?
Arab J Urol. 2019 Apr 8;17(1):77-81. doi: 10.1080/2090598X.2019.1589753. eCollection 2019 Mar.
8
Usefulness of Urinary Biomarkers for Assessing Bladder Condition and Histopathology in Patients with Interstitial Cystitis/Bladder Pain Syndrome.尿生物标志物在评估间质性膀胱炎/膀胱疼痛综合征患者膀胱状况和组织病理学中的作用。
Int J Mol Sci. 2022 Oct 10;23(19):12044. doi: 10.3390/ijms231912044.
9
Anxiety severity does not influence treatment outcomes in patients with interstitial cystitis/bladder pain syndrome.焦虑严重程度并不影响间质性膀胱炎/膀胱疼痛综合征患者的治疗效果。
Neurourol Urodyn. 2019 Aug;38(6):1602-1610. doi: 10.1002/nau.24019. Epub 2019 May 6.
10
Predictive Factors for a Satisfactory Treatment Outcome with Intravesical Botulinum Toxin A Injection in Patients with Interstitial Cystitis/Bladder Pain Syndrome.预测接受膀胱内注射肉毒杆菌毒素 A 治疗间质性膀胱炎/膀胱疼痛综合征患者疗效满意的因素。
Toxins (Basel). 2019 Nov 19;11(11):676. doi: 10.3390/toxins11110676.

引用本文的文献

1
Pathophysiology and potential multimodal therapeutic strategies for IC/BPS.间质性膀胱炎/膀胱疼痛综合征的病理生理学及潜在多模式治疗策略
Nat Rev Urol. 2025 May 15. doi: 10.1038/s41585-025-01044-4.
2
Videourodynamics - role, benefits and optimal practice.影像尿动力学检查——作用、益处及最佳实践
Nat Rev Urol. 2025 Mar;22(3):130-150. doi: 10.1038/s41585-024-00923-6. Epub 2024 Aug 29.
3
Clinical presentation, videourodynamic characteristics, and treatment outcome in men with interstitial cystitis-like lower urinary tract symptoms.
患有间质性膀胱炎样下尿路症状男性的临床表现、尿动力学特征及治疗结果
Int Urol Nephrol. 2022 Sep;54(9):2157-2165. doi: 10.1007/s11255-022-03294-2. Epub 2022 Jul 8.